EMA Authorised: Teduglutide Viatris (teduglutide) — Viatris Limited

View source ↗

Summary

EMA authorised Teduglutide Viatris for short bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Teduglutide Viatris (teduglutide)

Snippet

Status: Authorised. Therapeutic area: Short Bowel Syndrome. MAH: Viatris Limited. Decision date: 15/04/2026